In contrast, clock-interfering treatments such as inhibition of the cancer clock by shRNA-mediated knock-down, could significantly decrease proliferation and tumour growth in lymphatic cancer cells hallmarked by rhythmic clock gene expression. This evidence concerns the gene CLOCK and cancer.